NSCLC: three trials to keep an eye on
As the IASLC 2025 World Conference on Lung Cancer approaches, Clinical Trials Arena looks at some of the major Phase III assets you should keep an eye out for.
05 September 2025
05 September 2025
As the IASLC 2025 World Conference on Lung Cancer approaches, Clinical Trials Arena looks at some of the major Phase III assets you should keep an eye out for.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.